Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001019695-15-000054)

Filing Details

Accession Number:: 0001019695-15-000054
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-12-18 12:54:00
Reporting Period:: 2015-12-17

Filing Date:: 2015-12-18
Accepted Time:: 2015-12-18 12:54:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1019695	Arqule Inc	ARQL	Pharmaceutical Preparations (2834)	043221586

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233414	D Michael Loberg	C/O Arqule, Inc. 1 Wall Street, 6Th Floor Burlington MA 01803		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-17	3,719	$2.16	132,142	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects the weighted average price as the shares were purchased in multiple transactions. The per share transaction price ranged from $2.15 to $2.16. The Reporting Person hereby undertakes to provide, upon request, by the U.S. Securities and exchange commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.